Invenio Imaging Inc. news
SANTA CLARA, Calif., Oct. 12, 2021 /PRNewswire/ -- Invenio Imaging is proud to announce the 2000th case with the NIO Laser Imaging System, which uses Stimulated Raman Histology to provide microscopic images of fresh tissue specimens in minutes. NIO images can be shared digitally for immediate review by pathology, allowing closer collaboration between surgery and pathology.
SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD). This enables commercialization of this novel imaging system for intraoperative histology in the European market.
SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health technology companies chosen for their innovative technologies and patient impact.
2021 is the sixth year for the Rosenman Innovator selection cycle, which has the goal of identifying promising companies seeking funding from seed stage to Series A. The number of companies applying
With a deepening focus on unleashing novel applications of artificial intelligence (AI) across—and beyond—neurosurgery, a multidisciplinary team of physicians and mathematicians are collaborating on advanced approaches to diagnosis and patient care, developing data-driven methods that hold potential for progress across the continuum of medicine.
A Specialty Uniquely Poised to Lead with Data
Investigations into clinical applications for AI,
A new imaging technique and artificial intelligence (AI) are poised to significantly advance what neurosurgeons can do to help patients with brain tumors while they’re on the operatin